54008
1,2-二油酰基-sn-丙三基-3-磷酸乙醇胺
≥98.0% (TLC)
别名:
3-sn-磷脂酰乙醇胺, 1,2-二油酰, L-β,γ-二油酰-α-脑磷脂, DOPE, PE(18:1(9Z)/18:1(9Z)), 二油酰磷脂酰乙醇胺
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C41H78NO8P
化学文摘社编号:
分子量:
744.03
PubChem Substance ID:
UNSPSC Code:
12352211
Beilstein/REAXYS Number:
1718431
MDL number:
assay
≥98.0% (TLC)
form
solid
functional group
ester
lipid type
phosphoglycerides
storage temp.
−20°C
SMILES string
CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(=O)OCCN)OC(=O)CCCCCCC\C=C/CCCCCCCC
InChI
1S/C41H78NO8P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-40(43)47-37-39(38-49-51(45,46)48-36-35-42)50-41(44)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h17-20,39H,3-16,21-38,42H2,1-2H3,(H,45,46)/b19-17-,20-18-
InChI key
MWRBNPKJOOWZPW-CLFAGFIQSA-N
Application
1,2-二油酰-sn-甘油-3-磷酸乙醇胺（DOPE）可与N-[1-(2,3-二油酰氧基)丙基] -N,N,N-三甲基甲基硫酸铵（DOTAP）形成异质脂质体而作为治疗剂的运载工具。
Packaging
无底玻璃瓶。内含物装在插入的融合锥内。
Still not finding the right product?
Explore all of our products under 1,2-二油酰基-sn-丙三基-3-磷酸乙醇胺
存储类别
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
新产品
此项目有
Antonio A M Gasperini et al.
Langmuir : the ACS journal of surfaces and colloids, 31(11), 3308-3317 (2015-03-03)
This work presents a study of the association between low molecular weight hyaluronic acid (16 kDa HA) and cationic liposomes composed of egg phosphatidylcholine (EPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), and 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP). The cationic liposome/HA complexes were evaluated to determine their mesoscopic
S Peraramelli et al.
Journal of thrombosis and haemostasis : JTH, 12(11), 1826-1837 (2014-08-29)
TFPI is a Kunitz-type protease inhibitor that downregulates the extrinsic coagulation pathway by inhibiting factor Xa (FXa) and FVIIa. All three Kunitz domains (KD1, KD2, and KD3) and protein S are required for optimal inhibition of FXa and FVIIa. There
Ryo Furukawa et al.
Biomaterials, 57, 107-115 (2015-04-29)
Mitochondrial genome-targeting nucleic acids are promising therapeutic candidates for treating mitochondrial diseases. To date, a number of systems for delivering genetic information to the cytosol and the nucleus have been reported, and several successful gene therapies involving gene delivery targeted